CURRENT PHARMACOTHERAPY FOR KNEE OSTEOARTHRITIS: SPECIFIC FEATURES OF SYMPTOMATIC AND DISEASE MODIFYING EFFECTS. COMMUNICATION 1. SPECIFIC FEATURES OF THE SYMPTOMATIC EFFECTS OF CURRENT DRUGS TO TREAT KNEE OSTHEOARTHRITIS

CURRENT PHARMACOTHERAPY FOR KNEE OSTEOARTHRITIS: SPECIFIC FEATURES OF SYMPTOMATIC AND DISEASE MODIFYING EFFECTS. COMMUNICATION 1. SPECIFIC FEATURES OF THE SYMPTOMATIC EFFECTS OF CURRENT DRUGS TO TREAT KNEE OSTHEOARTHRITIS

Objective: to study the specific features of the symptomatic effect and tolerability of acetaminophen, glucosamine sulfate (GS), chondroitin sulfate (CS), and meloxicam in patents with knee osteoarthritis (OA). Subjects and methods. An 18-month open-label randomized prospective parallel-group trial...

Full description

Bibliographic Details
Main Authors: E. S. Tsvetkova, N. G. Ionichenok, L. N. Denisov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2015-03-01
Series:Научно-практическая ревматология
Subjects:
knee osteoarthritis
glucosamine sulfate
chondroitin sulfate
acetaminophen
meloxicam
symptomatic therapy
tolerability
Online Access:https://rsp.mediar-press.net/rsp/article/view/2040

Internet

https://rsp.mediar-press.net/rsp/article/view/2040

Similar Items